Exact Mass: 477.12460180000005
Exact Mass Matches: 477.12460180000005
Found 231 metabolites which its exact mass value is equals to given mass value 477.12460180000005
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
8-methylthiooctyl glucosinolate
Acquisition and generation of the data is financially supported by the Max-Planck-Society
CB3717
D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D000970 - Antineoplastic Agents
10-Propargyl-5,8-dideazafolic acid
(3,5-Dichlorophenyl)methyl 4-[3-oxo-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylate
C22H21Cl2N3O5 (477.08581960000004)
4-(7-(((1R)-1-((3-Chloro-2-thienyl)methyl)propyl)amino)-3H-imidazo(4,5-b)pyridin-3-yl)-N-ethyl-2,3-dihydroxycyclopentanecarboxamide, (1S,2R,3S,4R)-
C22H28ClN5O3S (477.16012880000005)
Isopropyl 4-(1-(2-fluoro-4-(methylsulfonyl)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)piperidine-1-carboxylate
ARN-509
Benoxaprofen glucuronide
C22H20ClNO9 (477.08265400000005)
ritanserin
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Ritanserin (R 55667) is a highly potent, relatively selective, orally active, long acting antagonist of 5-HT2 receptor, with an IC50 of 0.9 nM, less active on Histamine H1, Dopamine D2, Adrenergic α1, Adrenergic α2 receptors[1].
(S)-N-((1-(5-(4-Fluorophenyl)-2-methylthiazole-4-carbonyl)piperidin-2-yl)methyl)benzofuran-4-carboxamide
C26H24FN3O3S (477.15223260000005)
Malvidin 3-rhamnoside
Malvidin 3-rhamnoside is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Malvidin 3-rhamnoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Malvidin 3-rhamnoside can be found in common pea and grass pea, which makes malvidin 3-rhamnoside a potential biomarker for the consumption of these food products.
Isorhamnetin 7-alpha-D-Glucosamine
Ser Gln Asp Glu
C17H27N5O11 (477.17069919999994)
ritanserin
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Ritanserin (R 55667) is a highly potent, relatively selective, orally active, long acting antagonist of 5-HT2 receptor, with an IC50 of 0.9 nM, less active on Histamine H1, Dopamine D2, Adrenergic α1, Adrenergic α2 receptors[1].
Cys Met Pro Gln
Cys Met Gln Pro
Cys Asn Asn Gln
Cys Asn Gln Asn
Cys Pro Met Gln
Cys Pro Gln Met
Cys Gln Met Pro
Cys Gln Asn Asn
Cys Gln Pro Met
Asp Asp Asp Asn
Asp Asp Asn Asp
Asp Asp Gln Thr
C17H27N5O11 (477.17069919999994)
Asp Asp Thr Gln
C17H27N5O11 (477.17069919999994)
Asp Glu Asn Thr
C17H27N5O11 (477.17069919999994)
Asp Glu Gln Ser
C17H27N5O11 (477.17069919999994)
Asp Glu Ser Gln
C17H27N5O11 (477.17069919999994)
Asp Glu Thr Asn
C17H27N5O11 (477.17069919999994)
Asp Asn Asp Asp
Asp Asn Glu Thr
C17H27N5O11 (477.17069919999994)
Asp Asn Thr Glu
C17H27N5O11 (477.17069919999994)
Asp Gln Asp Thr
C17H27N5O11 (477.17069919999994)
Asp Gln Glu Ser
C17H27N5O11 (477.17069919999994)
Asp Gln Ser Glu
C17H27N5O11 (477.17069919999994)
Asp Gln Thr Asp
C17H27N5O11 (477.17069919999994)
Asp Ser Glu Gln
C17H27N5O11 (477.17069919999994)
Asp Ser Gln Glu
C17H27N5O11 (477.17069919999994)
Asp Thr Asp Gln
C17H27N5O11 (477.17069919999994)
Asp Thr Glu Asn
C17H27N5O11 (477.17069919999994)
Asp Thr Asn Glu
C17H27N5O11 (477.17069919999994)
Asp Thr Gln Asp
C17H27N5O11 (477.17069919999994)
Glu Asp Asn Thr
C17H27N5O11 (477.17069919999994)
Glu Asp Gln Ser
C17H27N5O11 (477.17069919999994)
Glu Asp Ser Gln
C17H27N5O11 (477.17069919999994)
Glu Asp Thr Asn
C17H27N5O11 (477.17069919999994)
Glu Glu Asn Ser
C17H27N5O11 (477.17069919999994)
Glu Glu Ser Asn
C17H27N5O11 (477.17069919999994)
Glu Asn Asp Thr
C17H27N5O11 (477.17069919999994)
Glu Asn Glu Ser
C17H27N5O11 (477.17069919999994)
Glu Asn Ser Glu
C17H27N5O11 (477.17069919999994)
Glu Asn Thr Asp
C17H27N5O11 (477.17069919999994)
Glu Gln Asp Ser
C17H27N5O11 (477.17069919999994)
Glu Gln Ser Asp
C17H27N5O11 (477.17069919999994)
Glu Ser Asp Gln
C17H27N5O11 (477.17069919999994)
Glu Ser Glu Asn
C17H27N5O11 (477.17069919999994)
Glu Ser Asn Glu
C17H27N5O11 (477.17069919999994)
Glu Ser Gln Asp
C17H27N5O11 (477.17069919999994)
Glu Thr Asp Asn
C17H27N5O11 (477.17069919999994)
Glu Thr Asn Asp
C17H27N5O11 (477.17069919999994)
Met Cys Pro Gln
Met Cys Gln Pro
Met Pro Cys Gln
Met Pro Gln Cys
Met Gln Cys Pro
Met Gln Pro Cys
Asn Cys Asn Gln
Asn Cys Gln Asn
Asn Asp Asp Asp
Asn Asp Glu Thr
C17H27N5O11 (477.17069919999994)
Asn Asp Thr Glu
C17H27N5O11 (477.17069919999994)
Asn Glu Asp Thr
C17H27N5O11 (477.17069919999994)
Asn Glu Glu Ser
C17H27N5O11 (477.17069919999994)
Asn Glu Ser Glu
C17H27N5O11 (477.17069919999994)
Asn Glu Thr Asp
C17H27N5O11 (477.17069919999994)
Asn Asn Cys Gln
Asn Asn Gln Cys
Asn Gln Cys Asn
Asn Gln Asn Cys
Asn Ser Glu Glu
C17H27N5O11 (477.17069919999994)
Asn Thr Asp Glu
C17H27N5O11 (477.17069919999994)
Asn Thr Glu Asp
C17H27N5O11 (477.17069919999994)
Pro Cys Met Gln
Pro Cys Gln Met
Pro Met Cys Gln
Pro Met Gln Cys
Pro Gln Cys Met
Pro Gln Met Cys
Gln Cys Met Pro
Gln Cys Asn Asn
Gln Cys Pro Met
Gln Asp Asp Thr
C17H27N5O11 (477.17069919999994)
Gln Asp Glu Ser
C17H27N5O11 (477.17069919999994)
Gln Asp Ser Glu
C17H27N5O11 (477.17069919999994)
Gln Asp Thr Asp
C17H27N5O11 (477.17069919999994)
Gln Glu Asp Ser
C17H27N5O11 (477.17069919999994)
Gln Glu Ser Asp
C17H27N5O11 (477.17069919999994)
Gln Met Cys Pro
Gln Met Pro Cys
Gln Asn Cys Asn
Gln Asn Asn Cys
Gln Pro Cys Met
Gln Pro Met Cys
Gln Ser Asp Glu
C17H27N5O11 (477.17069919999994)
Gln Ser Glu Asp
C17H27N5O11 (477.17069919999994)
Gln Thr Asp Asp
C17H27N5O11 (477.17069919999994)
Ser Asp Glu Gln
C17H27N5O11 (477.17069919999994)
Ser Asp Gln Glu
C17H27N5O11 (477.17069919999994)
Ser Glu Asp Gln
C17H27N5O11 (477.17069919999994)
Ser Glu Glu Asn
C17H27N5O11 (477.17069919999994)
Ser Glu Asn Glu
C17H27N5O11 (477.17069919999994)
Ser Glu Gln Asp
C17H27N5O11 (477.17069919999994)
Ser Asn Glu Glu
C17H27N5O11 (477.17069919999994)
Ser Gln Glu Asp
C17H27N5O11 (477.17069919999994)
Thr Asp Asp Gln
C17H27N5O11 (477.17069919999994)
Thr Asp Glu Asn
C17H27N5O11 (477.17069919999994)
Thr Asp Asn Glu
C17H27N5O11 (477.17069919999994)
Thr Asp Gln Asp
C17H27N5O11 (477.17069919999994)
Thr Glu Asp Asn
C17H27N5O11 (477.17069919999994)
Thr Glu Asn Asp
C17H27N5O11 (477.17069919999994)
Thr Asn Asp Glu
C17H27N5O11 (477.17069919999994)
Thr Asn Glu Asp
C17H27N5O11 (477.17069919999994)
Thr Gln Asp Asp
C17H27N5O11 (477.17069919999994)
Acridine mustard
C21H27Cl4N3O (477.09081320000007)
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D009676 - Noxae > D000477 - Alkylating Agents D009676 - Noxae > D009153 - Mutagens
Phosphinic amide,P,P-diphenyl-N-(triphenylphosphoranylidene)-
GW843682X
C22H18F3N3O4S (477.09700640000005)
Flutropium bromide
C24H29BrFNO3 (477.13147160000005)
C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C29714 - Mast Cell Stabilizer
1,3,4,6-TETRA-O-ACETYL-2-DEOXY-2-PHTHALIMIDO-BETA-D-GLUCOPYRANOSE
2-Cyclopropyl-3-[(diphenylphosphinyl)methyl]-4-(4-fluorophenyl)quinoline
ARN-509
L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BB - Anti-androgens C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen
(S)-N-((1-(5-(4-Fluorophenyl)-2-methylthiazole-4-carbonyl)piperidin-2-yl)methyl)benzofuran-4-carboxamide
C26H24FN3O3S (477.15223260000005)
10-Propargyl-5,8-dideazafolic acid
D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D000970 - Antineoplastic Agents
Sulopenem etzadroxil
C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Benzoic acid [5-(6-benzamido-9-purinyl)-3-fluoro-4-hydroxy-2-oxolanyl]methyl ester
C24H20FN5O5 (477.14484020000003)
2-(4-morpholinyl)-N-[(4-nitro-1H-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine
C21H19N9O3S (477.1331504000001)
2-[[4-(1,3-dioxo-2-isoindolyl)-1-oxobutyl]amino]-N-(2-furanylmethyl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide
C25H23N3O5S (477.13583480000005)
N-({(2s)-1-[(3r)-3-Amino-4-(3-Chlorophenyl)butanoyl]pyrrolidin-2-Yl}methyl)-3-(Methylsulfonyl)benzamide
C23H28ClN3O4S (477.1488958000001)
Pradigastat sodium
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor
Dermatan sulfate
C14H23NO15S (477.07883680000003)
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents D006401 - Hematologic Agents > D000925 - Anticoagulants
(2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
C14H23NO15S (477.07883680000003)
4-(7-(((1R)-1-((3-Chloro-2-thienyl)methyl)propyl)amino)-3H-imidazo(4,5-b)pyridin-3-yl)-N-ethyl-2,3-dihydroxycyclopentanecarboxamide, (1S,2R,3S,4R)-
C22H28ClN5O3S (477.16012880000005)
(S)-N-((1-(5-(4-Fluorophenyl)-2-methylthiazole-4-carbonyl)piperidin-2-yl)methyl)benzofuran-4-carboxamide
C26H24FN3O3S (477.15223260000005)
AUREOMYCIN
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-9-methylsulfanyl-N-sulfooxynonanimidothioate
N-(5-methyl-3-isoxazolyl)-2-[[1-[[3-(trifluoromethyl)phenyl]methyl]-3-indolyl]sulfonyl]acetamide
C22H18F3N3O4S (477.09700640000005)
alpha-D-GlcNAc6S-(1->4)-D-GlcA
C14H23NO15S (477.07883680000003)
A carbohydrate acid derivative that consists of D-glucuronic acid having a 6-O-sulfo-N-acetyl-alpha-D-glucosaminyl residue attached at position 4. An intermediate glycan in the degradation of heparan sulfate.
6-Amino-5-[2-[[4-(4-chlorophenyl)-5-[1-(dimethylamino)ethyl]-1,2,4-triazol-3-yl]sulfanyl]acetyl]-1,3-dimethylpyrimidine-2,4-dione
N-(6-ethoxy-1,3-benzothiazol-2-yl)-4-methoxy-3-(4-morpholinylsulfonyl)benzamide
3-[Ethyl(phenyl)sulfamoyl]-4-methylbenzoic acid (4-methyl-2-oxo-1-benzopyran-7-yl) ester
C26H23NO6S (477.12460180000005)
6-(butylsulfamoyl)-N-(2,2-dimethoxyethyl)-2-thiophen-2-yl-4-quinolinecarboxamide
C22H27N3O5S2 (477.13920520000005)
1-[4-(Benzenesulfonyl)-1-piperazinyl]-2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)thio]ethanone
C20H23N5O3S3 (477.09629680000006)
2-[[5-[(4-fluorophenoxy)methyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]sulfanyl]-N-(3-sulfamoylphenyl)acetamide
C20H20FN5O4S2 (477.09406920000004)
4-amino-N5-[2-(2-methoxyethylamino)-1-(5-methyl-2-furanyl)-2-oxoethyl]-N5-(thiophen-2-ylmethyl)isothiazole-3,5-dicarboxamide
2-Thiophenecarboxylic acid [3-(4-methoxy-4-oxobutyl)-7-methyl-6,8-dioxo-2-phenyl-7-isoquinolinyl] ester
C26H23NO6S (477.12460180000005)
2-(4-morpholinyl)-N-[(6-nitro-1H-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine
C21H19N9O3S (477.1331504000001)
3-chloro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C21H24ClN5O4S (477.1237454000001)
3-chloro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C21H24ClN5O4S (477.1237454000001)
3-chloro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C21H24ClN5O4S (477.1237454000001)
3-chloro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C21H24ClN5O4S (477.1237454000001)
3-chloro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C21H24ClN5O4S (477.1237454000001)
3-chloro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C21H24ClN5O4S (477.1237454000001)
3-chloro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C21H24ClN5O4S (477.1237454000001)
3-chloro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C21H24ClN5O4S (477.1237454000001)
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(4-phenoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid
C23H27NO8S (477.14573020000006)
[(3aS,4R,9bS)-1-(2-fluorophenyl)sulfonyl-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
C26H24FN3O3S (477.15223260000005)
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(4-phenoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid
C23H27NO8S (477.14573020000006)
(1R,9S,10S,11S)-12-(2-fluorophenyl)sulfonyl-10-(hydroxymethyl)-11-(morpholine-4-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(4-phenoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid
C23H27NO8S (477.14573020000006)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-8-methylsulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(2R,3R,6R)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3R,6R)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6S)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,5S,6R)-5-[[(2,5-difluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,5S,6R)-5-[[(2,5-difluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(4-phenoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid
C23H27NO8S (477.14573020000006)
[(3aR,4R,9bR)-1-(2-fluorophenyl)sulfonyl-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
C26H24FN3O3S (477.15223260000005)
(1S,9R,10R,11R)-12-(2-fluorophenyl)sulfonyl-10-(hydroxymethyl)-11-(morpholine-4-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-8-methylsulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-8-methylsulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(2S,3R,6S)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3S,6R)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6R)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3S,6S)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3R,6S)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,5R,6S)-5-[[(2,5-difluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,5R,6S)-5-[[(2,5-difluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(4-phenoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid
C23H27NO8S (477.14573020000006)
[(3aS,4S,9bS)-1-(2-fluorophenyl)sulfonyl-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
C26H24FN3O3S (477.15223260000005)
(2R,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
C14H23NO15S (477.07883680000003)
Butyl 4,7-DI(para-ethoxyphenyl)-1,2,5-thiadiazolo(3,4-C)pyridine-6-carboxylate
C26H27N3O4S (477.1722182000001)
chlortetracycline(1-)
An organic anion that is the major structure of chlortetracycline at pH 7.3 (according to Marvin v 6.2.0.).
Glutathione diethyl ester (TFA)
Glutathione diethyl ester (TFA) is a delivery agent for glutathione monoester, and thus for glutathione, in human cells and therefore could serve to decrease oxidative stress and toxicity[1].